Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy.

Samir V JenkinsDmitry A NedosekinEmily K MillerVladimir P Zharov Ruud P M Dings Jingyi Chen Robert J Griffin

Published in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2017)

These studies demonstrate Ax's potential as an effective targeting agent for Au-based theranostics to tumour and endothelial cells, enabling photothermal killing. This platform further suggests potential for multimodal in vivo therapy via next-generation drug-loaded nanocages.

Keyphrases

cancer therapy
endothelial cells
drug delivery
human health
photodynamic therapy
high throughput
sensitive detection
pain management
drug release
high glucose
vascular endothelial growth factor
cell therapy
case control
smoking cessation
electronic health record